30 October 2018
The consortium will be co-led by Professor Mel Mather, University of Nottingham, and Dr Philippe Wilson from De Montfort University Leicester (DMU).
A collaboration of researchers from the UK is pursuing a technique to detect breast cancer more quickly, thanks to funding from STFC and partners.
The consortium, led by De Montfort University Leicester (DMU) and the University of Nottingham, aims to develop and improve technologies for liquid biopsy – using blood or other bodily fluids to detect disease.
The most common diagnostic technique currently is an MRI scan, but this new innovative technique will be low-cost, portable and minimally invasive to patients.
Funding comes from STFC, the Engineering and Physical Sciences Research Council (EPSRC) and Cancer Research UK.
Dr Philippe Wilson from DMU said: "It's an honour to be funded by this very prestigious research council and charity partnership.
"The onus is to do something ground breaking for science, innovation and outreach."
For more information on the technique and the consortium behind it, visit the DMU website.
STFC is joining forces with EPSRC and Cancer Research UK for another round of funding, this time on the theme of artificial intelligence in clinical image analysis. Applications will be taken from Thursday (November 1) with a deadline of November 28, and more information is available online.